These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36702208)

  • 1. Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.
    Maeki T; Tajima S; Ando N; Wakimoto Y; Hayakawa K; Kutsuna S; Kato F; Taniguchi S; Nakayama E; Lim CK; Saijo M
    J Infect Chemother; 2023 May; 29(5):469-474. PubMed ID: 36702208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey].
    Tezcan S; Kızıldamar S; Ulger M; Aslan G; Tiftik N; Ozkul A; Emekdaş G; Niedrig M; Ergünay K
    Mikrobiyol Bul; 2014 Oct; 48(4):606-17. PubMed ID: 25492656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavivirus-induced antibody cross-reactivity.
    Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
    J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological cross-reactivity among common flaviviruses.
    Chan KR; Ismail AA; Thergarajan G; Raju CS; Yam HC; Rishya M; Sekaran SD
    Front Cell Infect Microbiol; 2022; 12():975398. PubMed ID: 36189346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
    Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
    Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of serological and molecular methods for diagnosis of zika virus infections.
    Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
    J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evidence of flaviviruses infection among acute febrile illness patients in Afghanistan.
    Elyan DS; Moustafa L; Noormal B; Jacobs JS; Aziz MA; Hassan KS; Wasfy MO; Monestersky JH; Oyofo BA
    J Infect Dev Ctries; 2014 Sep; 8(9):1176-80. PubMed ID: 25212082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
    Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of West Nile virus and tick-borne encephalitis virus in southeastern Turkey: first evidence for tick-borne encephalitis virus infections.
    Ergunay K; Ozer N; Us D; Ozkul A; Simsek F; Kaynas S; Ustacelebi S
    Vector Borne Zoonotic Dis; 2007; 7(2):157-61. PubMed ID: 17627432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence report on tick-borne encephalitis virus and Crimean-Congo hemorrhagic fever virus among Malaysian's farm workers.
    Mohd Shukri M; Ling Kho K; Ghane Kisomi M; Lani R; Marlina S; Muhd Radzi SF; Tee Tay S; Ping Wong L; Awang Mahmud AB; Hassan Nizam QN; Abu Bakar S; Zandi K
    BMC Public Health; 2015 Jul; 15():704. PubMed ID: 26205588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Zika Virus Serological Testing Strategies in New York State.
    Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.